The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Formulations Of Tnf-Alpha Antibodies - EP2822591

The patent EP2822591 was granted to Cadila Healthcare on May 2, 2018. The application was filed on Mar 5, 2013 under application number EP13742519A. The patent is currently recorded with a legal status of "Revoked".

EP2822591

CADILA HEALTHCARE
Application Number
EP13742519A
Filing Date
Mar 5, 2013
Status
Revoked
Jul 16, 2021
Publication Date
May 2, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BOULT WADE TENNANTFeb 1, 2019BOULT WADE TENNANTADMISSIBLE
GRUNECKER PATENT UND RECHTSANWALTE PARTG MBBFeb 1, 2019GRUNECKER PATENTADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO2007092772
INTERNATIONAL-SEARCH-REPORTWO2004016286
INTERNATIONAL-SEARCH-REPORTWO2010077422
OPPOSITIONEP2238985
OPPOSITIONIN0610MUM2012
OPPOSITIONIN1606MUM2012
OPPOSITIONIN3031MUM2012
OPPOSITIONWO2004016286
OPPOSITIONWO2004055164
OPPOSITIONWO2011104381
OPPOSITIONWO2012089778
OPPOSITIONWO2013011076
OPPOSITIONWO2013186230
OPPOSITIONWO2014039903

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents